title: A newly approved drug for a rare group of diseases: Dichlorphenamide for periodic paralysis.
authors: From Sorbonne Universités-UPMC Univ Paris 06 UMR 1127 (B.F.), INSERM UMR 1127 (B.F.), and CNRS, UMR 7225 (B.F.), Institut Cerveau Moelle-ICM, University Hospital Pitié-Salpêtrière; Assistance Publique-Hôpitaux de Paris (B.F.), National Reference Center for Neuromuscular Channelopathies, Department of Nervous System Diseases, University Hospital Pitié-Salpêtrière, Paris, France; and Department of Neurology (L.H.P.), University of Virginia, Charlottesville. bertrand.fontaine@aphp.fr.
authors: Bertrand
authors: B
authors: Fontaine
authors: From Sorbonne Universités-UPMC Univ Paris 06 UMR 1127 (B.F.), INSERM UMR 1127 (B.F.), and CNRS, UMR 7225 (B.F.), Institut Cerveau Moelle-ICM, University Hospital Pitié-Salpêtrière; Assistance Publique-Hôpitaux de Paris (B.F.), National Reference Center for Neuromuscular Channelopathies, Department of Nervous System Diseases, University Hospital Pitié-Salpêtrière, Paris, France; and Department of Neurology (L.H.P.), University of Virginia, Charlottesville.
authors: Lawrence H
authors: LH
authors: Phillips
mesh_terms: D004005:Dichlorphenamide; D006801:Humans; D020514:Hypokalemic Periodic Paralysis; D010245:Paralyses, Familial Periodic; D010243:Paralysis
chemical_list: D004005:Dichlorphenamide